Clinical Trial Update: Palbociclib and Pembrolizumab In Central Nervous System Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the combination of palbociclib and pembrolizumab for brain metastases; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• Palbociclib (palbociclib)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Metastatic Malignant Neoplasm to Brain, Recurrent Brain Metastases | Phase 2 | Status: RECRUITING